Literature DB >> 25851739

Latent tuberculosis infection screening in immigrants to low-incidence countries: a meta-analysis.

Jonathon R Campbell1, Wenjia Chen, James Johnston, Victoria Cook, Kevin Elwood, Jane Krot, Fawziah Marra.   

Abstract

BACKGROUND: Immigration from regions with a high incidence of tuberculosis (TB) has slowed the decline of TB in low-incidence regions. Targeted screening of new immigrants and treatment for latent TB infection (LTBI) is needed to reinvigorate this decline. This meta-analysis compares LTBI diagnostic tests by positive test prevalence and proportion of positive tests by TB incidence.
METHODS: A systematic literature search was performed and data extracted based on tuberculin skin test (TST) and/or interferon-gamma release assay (IGRA) use in immigrants. For the eight studies performing tests concurrently, data were compared by positive tests and concordance, while other studies comparing individual tests were analyzed based on demographic factors. Data were analyzed via meta-analysis.
RESULTS: Forty-five studies with a combined sample size of 93,249 individuals were included in the analyses, 2206 of which were from the eight concurrent studies. Odds of a positive TST were significantly higher than an IGRA (odds ratio 1.46; 95% confidence interval 1.07-2.01) and test agreement was moderate. Proportion of positive TST and IGRA tests increased with TB incidence, although not linearly.
CONCLUSION: TST and IGRA data relating to immigrants are lacking, especially long-term follow-up and comparative data. Further data are urgently needed to determine TB risks after immigration, long-term TB development, and treatment outcomes.

Entities:  

Mesh:

Year:  2015        PMID: 25851739     DOI: 10.1007/s40291-015-0135-6

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  69 in total

1.  Longitudinal incidence of tuberculosis in South-East Asian refugees after re-settlement.

Authors:  C R MacIntyre; A J Plant
Journal:  Int J Tuberc Lung Dis       Date:  1999-04       Impact factor: 2.373

2.  Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers.

Authors:  I Harstad; B A Winje; E Heldal; F Oftung; G W Jacobsen
Journal:  Int J Tuberc Lung Dis       Date:  2010-09       Impact factor: 2.373

3.  Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups.

Authors:  P Weinfurter; H M Blumberg; G Goldbaum; R Royce; J Pang; J Tapia; J Bethel; G H Mazurek; S Toney; R Albalak
Journal:  Int J Tuberc Lung Dis       Date:  2011-08       Impact factor: 2.373

4.  Prevalence of tuberculosis, hepatitis B virus, and intestinal parasitic infections among refugees to Minnesota.

Authors:  Alan R Lifson; Dzung Thai; Ann O'Fallon; Wendy A Mills; Kaying Hang
Journal:  Public Health Rep       Date:  2002 Jan-Feb       Impact factor: 2.792

5.  Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention.

Authors:  Gerald H Mazurek; Margarita E Villarino
Journal:  MMWR Recomm Rep       Date:  2003-01-31

6.  The health status of asylum seekers screened by Auckland Public Health in 1999 and 2000.

Authors:  Mark Hobbs; Catherine Moor; Tony Wansbrough; Lester Calder
Journal:  N Z Med J       Date:  2002-08-23

7.  Implementation of an interferon-gamma release assay to screen for tuberculosis in refugees and immigrants.

Authors:  Terri Simpson; Julie Tomaro; Cynthia Jobb
Journal:  J Immigr Minor Health       Date:  2013-08

8.  Tuberculosis screening by tuberculosis skin test or QuantiFERON-TB Gold In-Tube Assay among an immigrant population with a high prevalence of tuberculosis and BCG vaccination.

Authors:  John A Painter; Edward A Graviss; Hoang Hoa Hai; Duong Thi Cam Nhung; Tran Thi Thanh Nga; Ngan P Ha; Kirsten Wall; Le Thien Huong Loan; Matt Parker; Lilia Manangan; Rick O'Brien; Susan A Maloney; R M Hoekstra; Randall Reves
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

9.  Interferon-gamma assay in combination with tuberculin skin test are insufficient for the diagnosis of culture-negative pulmonary tuberculosis.

Authors:  Marcin Wlodarczyk; Wieslawa Rudnicka; Beata Janiszewska-Drobinska; Grzegorz Kielnierowski; Magdalena Kowalewicz-Kulbat; Marek Fol; Magdalena Druszczynska
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

Review 10.  Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis.

Authors:  A Roy; M Eisenhut; R J Harris; L C Rodrigues; S Sridhar; S Habermann; L Snell; P Mangtani; I Adetifa; A Lalvani; I Abubakar
Journal:  BMJ       Date:  2014-08-05
View more
  13 in total

1.  Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study.

Authors:  Christine S Ho; Pei-Jean I Feng; Masahiro Narita; Jason E Stout; Michael Chen; Lisa Pascopella; Richard Garfein; Randall Reves; Dolly J Katz
Journal:  Lancet Infect Dis       Date:  2021-09-06       Impact factor: 25.071

2.  A Pilot TB Screening Model in a U.S. Prison Population Using Tuberculin Skin Test and Interferon Gamma Release Assay Based on Country of Origin.

Authors:  Roxanne P Kerani; Adrienne E Shapiro; Lara B Strick
Journal:  J Correct Health Care       Date:  2021-10-14

3.  Comparison of QuantiFERON-TB Gold In-Tube (QFT-GIT) and tuberculin skin test (TST) for diagnosis of latent tuberculosis in haemodialysis (HD) patients: a meta-analysis of κ estimates.

Authors:  E Ayubi; A Doosti-Irani; A Sanjari Moghaddam; S Khazaei; K Mansori; S Safiri; M Sani; E Mostafavi
Journal:  Epidemiol Infect       Date:  2017-03-02       Impact factor: 4.434

4.  Predicting tuberculosis risk in the foreign-born population of British Columbia, Canada: study protocol for a retrospective population-based cohort study.

Authors:  Lisa A Ronald; Jonathon R Campbell; Robert F Balshaw; David Z Roth; Kamila Romanowski; Fawziah Marra; Victoria J Cook; James C Johnston
Journal:  BMJ Open       Date:  2016-11-25       Impact factor: 2.692

5.  Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada.

Authors:  Jonathon R Campbell; James C Johnston; Mohsen Sadatsafavi; Victoria J Cook; R Kevin Elwood; Fawziah Marra
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240

6.  Risk Factors for Indeterminate Outcome on Interferon Gamma Release Assay in Non-US-Born Persons Screened for Latent Tuberculosis Infection.

Authors:  Jody C Sharninghausen; Adrienne E Shapiro; David M Koelle; H Nina Kim
Journal:  Open Forum Infect Dis       Date:  2018-07-27       Impact factor: 3.835

7.  Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.

Authors:  Jonathon R Campbell; James C Johnston; Victoria J Cook; Mohsen Sadatsafavi; R Kevin Elwood; Fawziah Marra
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

Review 8.  The impact of migration on tuberculosis epidemiology and control in high-income countries: a review.

Authors:  Manish Pareek; Christina Greenaway; Teymur Noori; Jose Munoz; Dominik Zenner
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

9.  A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic.

Authors:  Elissa Rennert-May; Elisabeth Hansen; Toktam Zadeh; Valerie Krinke; Stan Houston; Ryan Cooper
Journal:  Can Respir J       Date:  2016-02-24       Impact factor: 2.409

10.  The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.

Authors:  Christina Greenaway; Manish Pareek; Claire-Nour Abou Chakra; Moneeza Walji; Iuliia Makarenko; Balqis Alabdulkarim; Catherine Hogan; Ted McConnell; Brittany Scarfo; Robin Christensen; Anh Tran; Nick Rowbotham; Marieke J van der Werf; Teymur Noori; Kevin Pottie; Alberto Matteelli; Dominik Zenner; Rachael L Morton
Journal:  Euro Surveill       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.